- Home
- PHAR vs CAC Comparison
PHAR vs CAC Comparison
Compare PHAR & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- CAC
- Stock Information
- Founded
- PHAR 1988
- CAC 1875
- Country
- PHAR Netherlands
- CAC United States
- Employees
- PHAR N/A
- CAC N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- CAC Major Banks
- Sector
- PHAR Health Care
- CAC Finance
- Exchange
- PHAR Nasdaq
- CAC Nasdaq
- Market Cap
- PHAR 618.3M
- CAC N/A
- IPO Year
- PHAR N/A
- CAC 1997
- Fundamental
- Price
- PHAR $8.42
- CAC $45.32
- Analyst Decision
- PHAR Strong Buy
- CAC Hold
- Analyst Count
- PHAR 3
- CAC 3
- Target Price
- PHAR $27.00
- CAC $48.33
- AVG Volume (30 Days)
- PHAR 5.6K
- CAC 87.0K
- Earning Date
- PHAR 03-13-2025
- CAC 01-28-2025
- Dividend Yield
- PHAR N/A
- CAC 3.74%
- EPS Growth
- PHAR N/A
- CAC 21.89
- EPS
- PHAR N/A
- CAC 3.62
- Revenue
- PHAR $285,745,000.00
- CAC $177,396,000.00
- Revenue This Year
- PHAR $20.08
- CAC N/A
- Revenue Next Year
- PHAR $9.22
- CAC $10.12
- P/E Ratio
- PHAR N/A
- CAC $12.27
- Revenue Growth
- PHAR 30.64
- CAC 10.05
- 52 Week Low
- PHAR $6.65
- CAC $28.62
- 52 Week High
- PHAR $13.20
- CAC $50.07
- Technical
- Relative Strength Index (RSI)
- PHAR 40.05
- CAC 59.96
- Support Level
- PHAR $7.95
- CAC $43.76
- Resistance Level
- PHAR $9.35
- CAC $46.49
- Average True Range (ATR)
- PHAR 0.52
- CAC 1.18
- MACD
- PHAR -0.16
- CAC 0.24
- Stochastic Oscillator
- PHAR 22.76
- CAC 81.18
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.